星海棋牌

The entity responsible for the processing of your personal data is:

星海棋牌 (CVR no. 21023884)

Carl Jacobsens Vej 30,

2500 Valby, Denmark

 

Contact details (if you have inquiries and/or questions to our processing of your personal data):

 

Your personal data may become part of the clinical trial database and paper files as needed for the implementation, performance, and record-keeping (archiving) of the clinical trial, in particular, your personal data may be processed to: 

 

a.   manage your involvement in the clinical trial and the participation of the investigative site;

b.   communicate with you and the investigative site in connection with the clinical trial; and

c.   support applications for approval of the product under investigation. 

Providing your personal data is necessary to take part in any clinical trial activities for 星海棋牌.

 

We may collect the following categories of ordinary personal data about you:

We do not process any special categories of personal data (sensitive personal data) about you.

 

We may process your personal data described above based on the following legal bases:

 

 

We may share your personal data with other companies within the 星海棋牌 group, our service providers, contractors, government agencies, researchers and with research institutions who will use your personal data only for the purposes described above; including relevant regulatory authorities if requested or if part of a submission.

 

Your personal data may be transferred within the EEA or to countries outside the EEA, which are not deemed to provide an adequate level of protection of your personal data compared to the EEA. Instead, we have provided appropriate safeguards as required by the GDPR Art. 46 (2) (c) through EU Standard Contractual Clauses (if applicable) and we follow the recommendations from the EDPB (European Data Protection Board) for transferring EU data to third countries.

When transferring your personal data to vendors in the United States, we may rely on their self-certification to the EU-US Data Privacy Framework () or, when this is not the case, on EU Standard Contractual Clauses.

You may obtain a copy of the EU Standard Contractual Clauses by contacting us at privacy@genmab.com.

Please note your personal data may be shared with regulatory authorities outside the EU as part of a submission for approval of the investigational product.

 

Your personal data will be stored for as long as required under applicable laws, rules and/or regulations, which may be for a period of 25 years after the completion of the clinical trial. The retention period may be extended if We are required to preserve your personal data in connection with litigation, investigations or other relevant proceedings.

 

In general, you have the following rights:

If you would like to exercise any of these rights, please contact us at privacy@genmab.com.

 

There may be conditions or limitations on these rights. It is therefore not certain for example you have the right of data portability in the specific case - this depends on the specific circumstances of the processing activity.

[1] Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April, 2016 (鈥淕DPR鈥�)